(3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile is a newly developed JAK2 inhibitor therapy aimed to improve MPN-associated splenomegaly and systemic symptoms. The opposite enantiomer of Ruxolitinib (R702000).
SKU | RCLST049889 |
---|---|
CAS number | 941685-37-6 |
Molecular Formula | C17H18N6 |
Catalog Number | RCLST049889 |
Chemical Name | (3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (ent-Ruxolitinib) |
Molecular Weight | 306.37 |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Stability | No Data Available |
Appearance | White Solid |
Storage Condition | -20°C Freezer |